Evidence map›Paper›PMID 42454373›Full record

ArticleNucleic acids research2026

Effects of single and double mutations on the MYC promoter G-quadruplex using a custom G4 DNA microarray: conformational landscape and nearby guanine compensation.

Jonathan Dickerhoff, Desiree Tillo, Jinho Jang, Danzhou Yang, Charles Vinson

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonathan DickerhoffBorch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States.ORCID 0000-0002-3197-9472
Desiree TilloCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.ORCID 0000-0003-3568-6148
Jinho JangBorch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States.
Danzhou YangBorch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, United States.ORCID 0000-0001-7489-7111
Charles VinsonCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDREW D MESECAR · 1985 to 2026
$43.4M
Targeting MYC promoter G-quadruplex for MYC inhibition by IndenoisoquinolinesR01CA177585 · NCI · UNIVERSITY OF ARIZONA · PI SINTIM, HERMAN O, YANG, DANZHOU · 2014 to 2025
$4.0M
Targeting PDGFR-b promoter vacancy G-quadruplex to suppress gene expressionR01CA296831 · NCI · PURDUE UNIVERSITY · PI YANG, DANZHOU · 2025 to 2025
$2.9M
Nucleolin recognition of MYC promoter G-quadruplex and its role in MYC regulation by MycG4-ligandsU01CA240346 · NCI · PURDUE UNIVERSITY · PI YANG, DANZHOU · 2020 to 2024
$2.1M
NCI NIH HHS P30 CA023168NCI NIH HHS R01 CA177585NCI NIH HHS R01 CA296831NCI NIH HHS U01 CA240346NIH HHS P30CA023168NIH HHS R01CA177585NIH HHS R01CA296831NIH HHS U01CA240346Purdue Institute for Cancer Research
6 · The paper itself

Abstract

Parallel DNA G-quadruplexes (G4) are key regulators of oncogene transcription. The MYC promoter G-quadruplex (MycG4) is a prototype parallel G4 and promising anticancer drug target. However, effects of DNA damage or mutations on their conformational landscape remain elusive. Systematic analysis of mutational effects is challenging because permutating G4-forming sequences creates a vast sequence space inaccessible to most experimental methods. Herein, using a custom G4-DNA microarray, we systematically examine all 2 145 possible single and double mutations of the MYC promoter G4. The results show no single or even double mutation completely prevents MYC G-quadruplex formation, emphasizing its exceptional robustness. Mutated MycG4 sequences can form G-quadruplexes with vacancies or bulges without the need to replace the damaged G-runs. Both length and position of a G-run determine its resilience against mutations. Intriguingly, our results reveal an efficient compensation mechanism for mutations involving nearby redundant G-residues to preserve G4 formation. Moreover, the most disruptive mutations involve two nonadjacent G-runs, which cannot be repaired by a single G-tract but can still be compensated by redundant guanines. These results provide critical insights into G-quadruplex folding, structural resilience, and damage tolerance, with implications for gene regulation and G4-targeted drug design.

Indexed as

G-QuadruplexesGuanineMutationPromoter Regions, GeneticProto-Oncogene Proteins c-mycOligonucleotide Array Sequence AnalysisGuanineProto-Oncogene Proteins c-myc

Identifiers

PMID42454373
PMCPMC13369326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.